Even if your right about inmed having competition with their drug pipeline. IMO it doesn't matter. You can take their pipeline out of the equation! Their Biosynthesis and Bioinformatics tools are their money maker! Being able biosynthesis 90-100 cannabinoid's identically can't be understated. That alone will make this a multi billion dollar company!
Market Data 
Markets 
AI
